Suggestions
Jonathan Dabora
Global Value and Access Director at Takeda Oncology
Jonathan Dabora is an entrepreneurial biopharmaceutical leader with extensive experience in various executive roles.1 He holds a Ph.D. in Biochemistry from the University of California-Berkeley and an MBA in Finance and Entrepreneurial Studies from UCLA Anderson School of Management.1
Dr. Dabora served as the Global Patient Value and Access Director (Hematology Franchise) at Takeda Oncology from 2020 to 2022.1 In this role, he drove the NINLARO global patient value and access strategy, leading to year-over-year double-digit growth for the $750 million brand.1
His career highlights include:
- Currently serving as Principal at Concord Life Sciences, LLC (2024-present)1
- Global Head of Data and Digital, Medical and Access at Takeda Oncology (2022-2024)1
- Various roles at Novartis, including Regional Disease Area Access Director and Associate Director Portfolio Management1
- Founder and CEO of Zorphion Therapeutics (2002-2006)1
- Venture Associate at CW Ventures (2001-2002)1
Dr. Dabora's expertise spans corporate development, portfolio and program management, patient value and access, digital strategy, due diligence, and valuation.1 He is known for his ability to lead cross-functional teams, drive innovation, and unlock enterprise value.1
